Leaflet ZOSTAVAX powder and solvent for injection suspension
Indicated for: prevention of herpes zoster
Route of administration: injectable
Substance: zoster vaccine (vaccine)
ATC: J07BK02 (Antiinfectives for systemic use | Viral vaccines | Varicella zoster vaccines)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
Store in the refrigerator as instructed in the leaflet.
Store protected from light.
The shingles vaccine is used to prevent shingles, a condition caused by the reactivation of the varicella-zoster virus (VZV) in individuals who have had chickenpox. Shingles is characterized by a painful rash and can lead to severe complications such as postherpetic neuralgia. The shingles vaccine stimulates the immune system to recognize and combat the virus, reducing the risk of disease occurrence and symptom severity.
There are two types of shingles vaccines: the live attenuated vaccine and the recombinant vaccine. The live attenuated vaccine is administered subcutaneously, while the recombinant vaccine is administered intramuscularly. Both are especially recommended for individuals over the age of 50.
Common side effects include pain at the injection site, fatigue, mild fever, and muscle aches. In rare cases, severe allergic reactions may occur.
The shingles vaccine is an important preventive measure for older adults, helping to reduce the incidence and impact of shingles on quality of life.
General data about ZOSTAVAX
- Substance: zoster vaccine
- Date of latest medicines list: 01-07-2013
- Product code: W51781002
- Pharmaceutical form: powder and solvent for injection suspension
- Quantity: 10
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.